A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

NCT07016802 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
Adult Growth Hormone Deficiency

Interventions

DRUG: GenSci134
DRUG: Placebo
DRUG: Recombinant Human Growth Hormone Injection (Norditropin®)

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.